109 related articles for article (PubMed ID: 10857911)
1. Synthesis, chelating properties towards gallium and biological evaluation of two N-substituted 3-hydroxy-4-pyridinones.
Santos MA; Grazina R; Neto AQ; Cantinho G; Gano L; Patrício L
J Inorg Biochem; 2000 Mar; 78(4):303-11. PubMed ID: 10857911
[TBL] [Abstract][Full Text] [Related]
2. Alkylaryl-amino derivatives of 3-hydroxy-4-pyridinones as aluminium chelating agents with potential clinical application.
Chaves S; Gil M; Marques S; Gano L; Santos MA
J Inorg Biochem; 2003 Sep; 97(1):161-72. PubMed ID: 14507473
[TBL] [Abstract][Full Text] [Related]
3. N-Carboxyalkyl derivatives of 3-hydroxy-4-pyridinones: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation.
Santos MA; Gil M; Marques S; Gano L; Cantinho G; Chaves S
J Inorg Biochem; 2002 Sep; 92(1):43-54. PubMed ID: 12230987
[TBL] [Abstract][Full Text] [Related]
4. Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation with 67Ga.
Santos MA; Gil M; Gano L; Chaves S
J Biol Inorg Chem; 2005 Aug; 10(5):564-80. PubMed ID: 16133203
[TBL] [Abstract][Full Text] [Related]
5. A new bis(3-hydroxy-4-pyridinone)-IDA derivative as a potential therapeutic chelating agent. Synthesis, metal-complexation and biological assays.
Amélia Santos M; Gama S; Gano L; Cantinho G; Farkas E
Dalton Trans; 2004 Nov; (21):3772-81. PubMed ID: 15510305
[TBL] [Abstract][Full Text] [Related]
6. Potential 67Ga radiopharmaceuticals for myocardial imaging: tris(1-aryl-3-hydroxy-2-methyl-4-pyridinonato)gallium(III) complexes.
Zhang Z; Lyster DM; Webb GA; Orvig C
Int J Rad Appl Instrum B; 1992 Apr; 19(3):327-35. PubMed ID: 1629022
[TBL] [Abstract][Full Text] [Related]
7. N-Arylamine derivatives of 3-hydroxy-4-pyridinones: solution studies and bioevaluation in view of Al-detoxification roles.
Santos MA; Gil M; Marques S; Gano L; Chaves S
Anal Bioanal Chem; 2005 Jan; 381(2):413-9. PubMed ID: 15455189
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
Dobbin PS; Hider RC; Hall AD; Taylor PD; Sarpong P; Porter JB; Xiao G; van der Helm D
J Med Chem; 1993 Aug; 36(17):2448-58. PubMed ID: 8355246
[TBL] [Abstract][Full Text] [Related]
9. New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation.
Grazina R; Gano L; Sebestík J; Amelia Santos M
J Inorg Biochem; 2009 Feb; 103(2):262-73. PubMed ID: 19062099
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies of lanthanide complexes for the treatment of osteoporosis.
Mawani Y; Cawthray JF; Chang S; Sachs-Barrable K; Weekes DM; Wasan KM; Orvig C
Dalton Trans; 2013 May; 42(17):5999-6011. PubMed ID: 23299719
[TBL] [Abstract][Full Text] [Related]
11. New hydroxybenzyl and hydroxypyridylmethyl substituted triazacyclononane ligands for use with gallium(III) and indium(III).
Jones-Wilson TM; Motekaitis RJ; Sun Y; Anderson CJ; Martell AE; Welch MJ
Nucl Med Biol; 1995 Oct; 22(7):859-68. PubMed ID: 8547883
[TBL] [Abstract][Full Text] [Related]
12. Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxyl-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium(IV) chelation.
Xu J; Kullgren B; Durbin PW; Raymond KN
J Med Chem; 1995 Jul; 38(14):2606-14. PubMed ID: 7629800
[TBL] [Abstract][Full Text] [Related]
13. Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties, and biological activity.
Streater M; Taylor PD; Hider RC; Porter J
J Med Chem; 1990 Jun; 33(6):1749-55. PubMed ID: 2342069
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.
Rangel M; Leite A; João Amorim M; Garribba E; Micera G; Lodyga-Chruscinska E
Inorg Chem; 2006 Oct; 45(20):8086-97. PubMed ID: 16999406
[TBL] [Abstract][Full Text] [Related]
15. Tailored Gallium(III) chelator NOPO: synthesis, characterization, bioconjugation, and application in preclinical Ga-68-PET imaging.
Simeček J; Zemek O; Hermann P; Notni J; Wester HJ
Mol Pharm; 2014 Nov; 11(11):3893-903. PubMed ID: 24350645
[TBL] [Abstract][Full Text] [Related]
16. Ga[NO2A-N-(α-amino)propionate] chelates: synthesis and evaluation as potential tracers for ⁶⁸Ga PET.
Ferreira MF; Pereira G; André JP; Prata MI; Ferreira PM; Martins JA; Geraldes CF
Dalton Trans; 2014 Jun; 43(21):8037-47. PubMed ID: 24718365
[TBL] [Abstract][Full Text] [Related]
17. Specific sequestering agents for the actinides. 21. Synthesis and initial biological testing of octadentate mixed catecholate-hydroxypyridinonate ligands.
Uhlir LC; Durbin PW; Jeung N; Raymond KN
J Med Chem; 1993 Feb; 36(4):504-9. PubMed ID: 8386249
[TBL] [Abstract][Full Text] [Related]
18. Bis(3-hydroxy-4-pyridinone)-EDTA derivative as a potential therapeutic Al-chelating agent. Synthesis, solution studies and biological assays.
Santos MA; Gama S; Gano L; Farkas E
J Inorg Biochem; 2005 Sep; 99(9):1845-52. PubMed ID: 16099511
[TBL] [Abstract][Full Text] [Related]
19. Iron(III) chelating resins II. 3-Hydroxy-4(1H)-pyridinones-sepharose gels.
Feng M; van der Does L; Bantjes A
J Biomater Sci Polym Ed; 1992; 4(2):145-54. PubMed ID: 1486065
[TBL] [Abstract][Full Text] [Related]
20. Gallium(III) chelates of mixed phosphonate-carboxylate triazamacrocyclic ligands relevant to nuclear medicine: Structural, stability and in vivo studies.
Prata MIM; André JP; Kovács Z; Takács AI; Tircsó G; Tóth I; Geraldes CFGC
J Inorg Biochem; 2017 Dec; 177():8-16. PubMed ID: 28918355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
